Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Original Articles: Thrombosis"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 3, Pp 447-455 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Introduction The thrombin generation (TG) test is a global hemostasis assay sensitive to procoagulant conditions. However, some TG assays may underestimate elevated TG when the thrombin fluorogenic substrate is depleted or fluorescence is attenuated
Autor:
Verónica Bravo Villa, Job Romero, Patricia Baz, Eunice Rojas‐Zaldivar, María del Rosario Villa‐Márquez, Martha Cervantes, Gabriela Cesarman-Maus
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 3, Pp 421-425 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Introduction Apixaban, a direct factor Xa inhibitor, has been shown to be at least as safe and probably more effective than dalteparin for the treatment of cancer‐associated thrombosis (CAT) as reported in the ADAM‐VTE and Caravaggio studies, whi
Autor:
Walter Ageno, Miriam Tamm, Sylvia Haas, Alexander G.G. Turpie, Martin Gebel, Jonas Schneider, Danja Monje, Elizabeth Zell, Jörg-Peter Bugge, Lorenzo G. Mantovani, Reinhold Kreutz
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 3, Pp 426-438 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Background: The XALIA and XALIA-LEA prospective, noninterventional studies investigated the safety and effectiveness of rivaroxaban versus standard anticoagulation for venous thromboembolism (VTE) treatment in routine clinical practice across global
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 2, Pp 301-307 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Background Patients diagnosed with pulmonary embolism (PE) are reported to experience symptoms of posttraumatic stress disorder (PTSD) and existential anxiety following their diagnosis. They may also experience negative changes in perspective and hyp
Autor:
Kevin Coppa, Marty Lesser, Matthew A. Barish, Dimitrios Giannis, Alex C. Spyropoulos, Nina Kohn, Stuart L. Cohen, Saurav Chatterjee, Jamie S. Hirsch, Thomas McGinn, Mark Goldin, Eugenia Gianos
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 2, Pp 296-300 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Background Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID-19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high-risk patients. To date, no clear approach exist
Autor:
Amy W. Shaheen, Derek Saccoccio, Harish Eswaran, Tristan Long, Stephan Moll, Jamie A. Jarmul, David Meaux
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 2, Pp 292-295 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Background Coronavirus disease 2019 (COVID‐19) is associated with high rates of thromboembolic events in hospitalized patients. It remains to be determined if this risk persists following hospital discharge. Methods We conducted a retrospective coh
Autor:
Joseph W Jackson, M J Weinstein, Dorothy E. Scott, Mikhail V Ovanesov, Leonid A. Parunov, Samuel A. Woodle, Timothy K Lee, Yideng Liang, Stepan S Surov
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 211-222 (2021)
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 211-222 (2021)
Background Activated coagulation factor XIa (FXIa) is an impurity and primary source of procoagulant activity in thrombosis‐implicated immune globulin (IG) products. Several assays, of varying quality and precision are used to assess FXIa‐like pr
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 142-147 (2021)
Blondon, Marc; Limacher, Andreas; Righini, Marc; Aujesky, Drahomir; Méan, Marie (2021). Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort. Research and practice in thrombosis and haemostasis, 5(1), pp. 142-147. Wiley 10.1002/rth2.12361
Research and practice in thrombosis and haemostasis, vol. 5, no. 1, pp. 142-147
Research and Practice in Thrombosis and Haemostasis
Blondon, Marc; Limacher, Andreas; Righini, Marc; Aujesky, Drahomir; Méan, Marie (2021). Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort. Research and practice in thrombosis and haemostasis, 5(1), pp. 142-147. Wiley 10.1002/rth2.12361
Research and practice in thrombosis and haemostasis, vol. 5, no. 1, pp. 142-147
Research and Practice in Thrombosis and Haemostasis
Background Hospital‐associated venous thromboembolism (HA‐VTE) can be prevented by pharmacologic thromboprophylaxis. Thrombotic risk assessment models (RAMs) are essential tools to improve inadequately prescribed thromboprophylaxis. Among cases o
Autor:
Summer Syed, Joanne Duncan, Alex C. Spyropoulos, Mansoor Radwi, Sam Schulman, James D. Douketis, Na Li, Samer Narouze
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 159-167 (2021)
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 159-167 (2021)
Background The perioperative management of patients taking a direct oral anticoagulant (DOAC) who require a high‐bleed‐risk surgery and/or neuraxial anesthesia is uncertain. We surveyed clinician practices relating to DOAC interruption and relate
Autor:
Julien Demagny, Anoosha Habibi, Sandrine Benghezal, Aurélie Driss, Françoise Driss, Alain Stepanian, Louis Affo, Nadia Anguel, Agnès Veyradier, Paul Coppo, Sophie Capdenat, Damien Roux
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 197-203 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Wiley, 2020, 5 (1), pp.197-203. ⟨10.1002/rth2.12460⟩
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Wiley, 2020, 5 (1), pp.197-203. ⟨10.1002/rth2.12460⟩
International audience; Background: Sickle cell disease (SCD) is characterized by vaso‐occlusive crisis (VOC), acute chest syndrome (ACS) and multiorgan failure (MOF) complicated by thrombosis. Von Willebrand factor (VWF) is a strong marker of SCD